CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- 3 Insider Initial Statement of Ownership
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Other events
- CT ORDER Other Confidential Order
- 8-K Event Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Material agreement
- 8-K Event Material agreement
- 3/A Insider 3/A
- 4 Insider Changes in Ownership
- 5 Insider Annual Insider Trading Report
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
Page 42 of 53 · 1,049 filings